James E. Flynn 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 3:59 pm Sale | 2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | James E. Flynn | 0 0.000% | -2,414,897 (Position Closed) | Filing |
| 2022-09-23 5:15 pm Purchase | 2022-09-22 | 13G | Phathom Pharmaceuticals, Inc. PHAT | James E. Flynn | 2,414,897 5.810% | 2,414,897 (New Position) | Filing |